GPS2 and gastric cancer: These potentially new gastric cancer driver genes, as well as genes with high nonclonal mutation frequency, such as STK11, GPS2, NDUFB9, and AXIN2, represent good candidates for inclusion in future studies of gastric tumorigenesis.